EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Amyloid Precursor Protein and Alzheimer’s Disease

Kseniia S Orobets, Andrey L Karamyshev iD

International Journal of Molecular Sciences · 30.09.2023 · 24 (19) · 14794

DOI: 10.3390/ijms241914794 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.09.2023. Verfasst von Kseniia S Orobets und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 133-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Center of Excellence for Translational Neuroscience and Therapeutics (CTNT) and the TTUHSC Office of Research, Center of Excellence for Translational Neuroscience and Therapeutics (CTNT) and the TTUHSC Office of Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders associated with age or inherited mutations. It is characterized by severe dementia in the late stages that affect memory, cognitive functions, and daily life overall. AD progression is linked to the accumulation of cytotoxic amyloid beta (Aβ) and hyperphosphorylated tau protein combined with other pathological features such as synaptic loss, defective energy metabolism, imbalances in protein, and metal homeostasis. Several treatment options for AD are under investigation, including antibody-based therapy and stem cell transplantation. Amyloid precursor protein (APP) is a membrane protein considered to play a main role in AD pathology. It is known that APP in physiological conditions follows a non-amyloidogenic pathway; however, it can proceed to an amyloidogenic scenario, which leads to the generation of extracellular deleterious Aβ plaques. Not all steps of APP biogenesis are clear so far, and these questions should be addressed in future studies. AD is a complex chronic disease with many factors that contribute to disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansAmyloid beta-PeptidesAmyloid beta-Protein PrecursorMembrane Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseSRP-dependent targetingamyloid betaamyloid precursor protein (APP)membrane proteinsneurodegenerative diseaseprotein biogenesisprotein transport

Substanzen

Amyloid beta-PeptidesAmyloid beta-Protein PrecursorMembrane ProteinsAPP protein, human

Autor:innen und Institutionen

  • Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

ORCID-Profile: Andrey L Karamyshev

Förderung

  • the Center of Excellence for Translational Neuroscience and Therapeutics (CTNT) and the TTUHSC Office of Research
  • Center of Excellence for Translational Neuroscience and Therapeutics (CTNT) and the TTUHSC Office of Research

Zitieren

APA

Orobets, K. S., & Karamyshev, A. L. (2023). Amyloid Precursor Protein and Alzheimer’s Disease. International Journal of Molecular Sciences, 24(19), 14794. https://doi.org/10.3390/ijms241914794

Vancouver

Orobets KS, Karamyshev AL. Amyloid Precursor Protein and Alzheimer’s Disease. International Journal of Molecular Sciences. 2023;24(19):14794. doi:10.3390/ijms241914794

BibTeX
@article{Orobets2023,
  author = {Orobets, Kseniia S and Karamyshev, Andrey L},
  title = {Amyloid Precursor Protein and Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {19},
  pages = {14794},
  doi = {10.3390/ijms241914794}
}
Kostenlos starten →